DNA vs AMGN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
DNA
AMGN
Investment Advisor Scores
AMGN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DNA | AMGN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 16.6667 | Tie |
| PEG Ratio | 0 | 2.4515 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -48.5% | 9.5% | AMGN |
| Earnings Growth | 0.0% | 64.9% | AMGN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.5/100 | 35.4/100 | DNA |
| Profit Margin | -219.6% | 22.9% | AMGN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | DNA |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DNA
NeutralMixed signals - no dominant trend phase, RSI 46
AMGN
MarkupPrice above SMA50, rising 50-day trend (3.1% over 20 days), RSI 61
Fundamentals Snapshot
| Metric | DNA | AMGN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.4 | 18.3 |
| Trailing P/E | — | 27.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | -2.8% | 0.4% |
| EPS | -5.06 | 16.10 |
| Dividend Yield | — | 0.02% |